Tetravalent influenza virus subunit vaccine (Gazo Biotech/Liaoning Maokangyuan Biotechnology)

四价流感病毒亚单位疫苗（中逸安科/辽宁茂康源）

Report date: 2023/09/27 15:22:56

Base Information

Drug NameTetravalent influenza virus subunit vaccine (Gazo Biotech/Liaoning Maokangyuan Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGazo Biotech Co LtdLiaoning Maokangyuan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGazo Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A